Indication

Chronic hepatitis C - genotype 2

Chronic hepatitis C - genotype 2 refers to a persistent infection of the liver lasting longer than six months, specifically caused by genotype 2 strains of the hepatitis C virus (HCV). Read more about Chronic hepatitis C - genotype 2

29 drugs 13 manufacturers

Advertisement

Drugs that treat it

Common Chronic hepatitis C - genotype 2 therapies.

Showing 10–18 of 29 drugs

RIBAVIRIN

CHRONIC HEPATITIS C - GENOTYPE 1·+3
SANDOZ

RIBAVIRIN

CHRONIC HEPATITIS C - GENOTYPE 1·+3
RICHMOND PHARM

RIBAVIRIN

RIBAVIRIN·CHRONIC HEPATITIS C - GENOTYPE 1·+3
ZYDUS PHARMACEU

RIBAVIRIN

CHRONIC HEPATITIS C - GENOTYPE 1·+3
SANDOZ

RIBAVIRIN

CHRONIC HEPATITIS C - GENOTYPE 1·+3
RICHMOND PHARM

RIBAVIRIN

RIBAVIRIN·CHRONIC HEPATITIS C - GENOTYPE 1·+3
AUROBINDO PHARM
Filter & compare in the drug finder →Opens the drug finder with Chronic hepatitis C - genotype 2 preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Chronic hepatitis C - genotype 2.

Chronic hepatitis C - genotype 2 refers to a persistent infection of the liver lasting longer than six months, specifically caused by genotype 2 strains of the hepatitis C virus (HCV).

This viral subtype primarily affects hepatocytes, driving progressive hepatic inflammation, necrosis, and subsequent fibrogenesis.

While patients frequently remain asymptomatic for decades, unresolved infection can advance to severe complications, including compensated or decompensated liver cirrhosis, portal hypertension, hepatic failure, and hepatocellular carcinoma.

Identifying genotype 2 via molecular diagnostic testing is essential for confirming chronicity and tailoring therapeutic regimens, as distinct HCV genotypes demonstrate variable susceptibility and responsiveness to different antiviral drug classes.

Personalize your experience

Follow Chronic hepatitis C - genotype 2 and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it